New cancer clinical trial: Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

Published on: April 25, 2018 at 12:00PM
Condition:   Cancer
Interventions:   Drug: Gemcitabine;   Drug: Nab-paclitaxel
Sponsors:   Emory University;   Celgene Corporation
Not yet recruiting
https://ift.tt/2Ht6FS2